Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008835 |
ID: | TCMBANKHE008835 |
植物拉丁名: |
|
功能与主治: | 1. To resolve phlegm and stop cough; 2. To conduct qi downward/1. Treatmant of cough due to invasion by exogenous pathogenic factors. Swallowwort rhizome (Baiqian) is used with Schizonepeta (Jingjie) and Platycodon root (Jiegeng) in the formula Zhisuo San. 2. Treatment of turbid phlegm blocking the lungs |
药用植物名: | 白前 |
药味: | Minor Warm; Pungent; Bitter |
经络: | Lung |
治疗类型: | 化痰药 |
TCM_ID_id: | 6108 |
SymMap_id: | 19 |
TCMSP_id: | 34 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000706 | glaucogenin b | C21H28O7 | 392.4 g/mol | CC12CC(C(CC1=CC(C3C2CCC4=COC5(C4C(CO5)OC3=O)C)O)O)O | |
| TCMBANKIN001618 | c.glaucescens | ||||
| TCMBANKIN002824 | glaucogenin,a | glaucoside C_qt | C41H62O15 | 794.92 | |
| TCMBANKIN003022 | cynatratoside f,glaucoside h | cynatratoside f, glaucoside h | |||
| TCMBANKIN003350 | glaucoside C | C41H62O15 | 794.92 | CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC7=COC8(C7C(CO8)OC6=O)C)C)C)OC)O | |
| TCMBANKIN003611 | hypotuberostemonine | ||||
| TCMBANKIN005654 | cynanchol | CC(=O)C1=C(C(=C(C=C1)O)C2=C(C3=C(C=C2)C(O3)(C)C(=O)C)O)O | |||
| TCMBANKIN008679 | glaucoside B | glaucoside b | C42H64O15 | 808.95 | |
| TCMBANKIN009124 | Tylophorinidine | 32523-69-6; tylophorinidine; 36614-30-9; Dibenzo(f,h)pyrrolo(1,2-b)isoquinoline-6,14-diol, 9,11,12,13,13a,14-hexahydro-3,7-dimethoxy-, (13aS-trans)- | C22H23NO4 | 365.42 | COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3O)C5=CC(=C(C=C52)O)OC |
| TCMBANKIN011556 | stemonine | Spiro(furan-2(5H),2'-(2H)-furo(3,2-c)pyrrolo(1,2-a)azepin)-5-one, 1'-ethyl-1',3'a,4',5',6',8',9',10',10'a,10'b-decahydro-4-methyl-8'-(tetrahydro-4-methyl-5-oxo-2-furanyl)-; 69772-72-1; AC1L4E2D; stemoninine; Stemonine | C22H33NO4 | 375.5 | CCC1C2C3CCC(N3CCCC2OC14C=C(C(=O)O4)C)C5CC(C(=O)O5)C |
| TCMBANKIN013569 | glaucogenin c3-o-β-d-cymaropyranosyl-(1→4)-α-l-diginopyranosyl-(1→4)-β-d-thevetopyranoside | C42H64O15 | CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(C(C3OC)O)OC4CCC5(C6CCC7=COC8(C7C(CO8)OC(=O)C6CC=C5C4)C)C)C)C)OC)O | ||
| TCMBANKIN014437 | glaucoside H_qt | C47H72O20 | 957.06 | ||
| TCMBANKIN018146 | glaocogenin cmono-d-thevetoside | C28H40O9 | CC1C(C(C(C(O1)OC2CCC3(C4CCC5=COC6(C5C(CO6)OC(=O)C4CC=C3C2)C)C)O)OC)O | ||
| TCMBANKIN018332 | sinostemonine | ||||
| TCMBANKIN020524 | hodorine | C19H31NO5 | |||
| TCMBANKIN025379 | glaucoside a | C28H40O9 | 520.6 g/mol | CC1C(C(CC(O1)OC2CC3=CCC4C(C3(CC2O)C)CCC5=COC6(C5C(CO6)OC4=O)C)OC)O | |
| TCMBANKIN026741 | paipunine | CCN1CC2(CCCC34C2CC(C31)C56C4C(C(CC5)C(=C6)COCCN7CC89C(CCC12C8CC(CC1)C(=C)C2O)C1(C7OC9CC1)C)O)C | |||
| TCMBANKIN027016 | sessilistemonine | ||||
| TCMBANKIN030593 | cynanversicoside | ||||
| TCMBANKIN031478 | atratoside a, b, c, c, d | ||||
| TCMBANKIN037707 | atratoside d | C40H60O13 | |||
| TCMBANKIN039006 | atratoside a | C42H64O13 | 776.9 g/mol | CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC(C6=O)(C)C7=C(OC=C7)C)C)C)OC)O | |
| TCMBANKIN039292 | atratoside c | C48H72O18 | |||
| TCMBANKIN039884 | stemonidine | C19H29NO5 | 351.4 g/mol | CC1CC(OC1=O)C2CCC3N2CCCC(C34CC(C(=O)O4)C)OC | |
| TCMBANKIN040682 | cynatroside B | C41H62O14 | 779 | [C@]1([H])(O[H])[C@@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]3([H])[C@@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]4([H])C([H])([H])C(=C([H])C([H])([H])[C@] 5([H])[C@]6([H])C([H])([H])C([H])([H])[C@](O[H])(c7c(C([H])([H])[H])oc([H])c7[H])C5=O)[C@@]6(C([H])([H])[H])C([H])([H])[C@@]4([H])O[H])C([H])([H])[C@]3([H])OC([H])([H])[H])C([H])([H])[C@]2([H])OC([H]) ([H])[H])C([H])([H])[C@]1([H])OC([H])([H])[H] | |
| TCMBANKIN043294 | neocynanversicoside | C29H40O11 | |||
| TCMBANKIN043552 | Atratoglaucoside B | CHEMBL447384; ATRATOGLAUCOSIDE B | 839 | ||
| TCMBANKIN044688 | protostemonine | Isoprotostemonine | C23H31NO6 | 417 | N12[C@@]([H])(C([H])([H])C([H])([H])[C@@]1([H])[C@]3([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O3)[C@]4([H])[C@]([H])(O\C(=C(/C(OC([H])([H])[H])=C(C([H])([H])[H])C5=O)\O5)\[C@@]4([H])C([H])([H])[H] )C([H])([H])C([H])([H])C2([H])[H] |
| TCMBANKIN045502 | 26,27-bisnor-8,14-dioxo-α-onocerin | C132H130N8S4 | CCCCCCCCN1C2=C(C=C(C=C2)C=CC3=CC=C(C=C3)C4=C5C=CC(=C(C6=NC(=C(C7=CC=C(N7)C(=C8C=CC4=N8)C9=CC=C(C=C9)C=CC2=CC3=C(C=C2)N(C2=CC=CC=C2S3)CCCCCCCC)C2=CC=C(C=C2)C=CC2=CC3=C(C=C2)N(C2=CC=CC=C2S3)CCCCCCCC)C=C6)C2=CC=C(C=C2)C=CC2=CC3=C(C=C2)N(C2=CC=CC=C2S3)CCCCCCCC)N5)SC2=CC=CC=C21 | ||
| TCMBANKIN046759 | Atratoglaucoside A | 650.8 g/mol | |||
| TCMBANKIN046923 | Atratoside B | ||||
| TCMBANKIN048070 | glaucogenin A | C21H28O6 | 360.444 | [C@]1([H])(O[H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])C(=C([H])O4)[C@@]([H])([C@]4(C([H])([H])[H])OC5([H])[H])[C@]5([H])OC3=O)C([H])([H])[C@@]1 ([H])O[H] | |
| TCMBANKIN048329 | Glaucoside H | 87741-80-8; 6H-2,3,5-Trioxapentaleno(1',6':5,6,7)cyclonona(1,2-a)naphthalen-6-one, 10-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-3-O-methyl-alpha-L-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-L-ribo-hexopyrano | C47H72O20 | 957.06 | CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3CC4=CCC5C(C4(CC3O)C)CCC6=COC7(C6C(CO7)OC5=O)C)C)O)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)OC |
| TCMBANKIN050377 | cynajapogenin a | C20H26O4 | 330.4 g/mol | CC1=C(C=CO1)C2CCC3C(C2=O)CC=C4C3(CC(C(C4)O)O)C | |
| TCMBANKIN057142 | Ruvoside | UN2330; 1120-21-4; CAS-1120-21-4; LTBB002321; LS-158394; UN 2330; UNII-JV0QT00NUE; DSSTox_CID_1689; AI3-21126; U203; ACMC-209t6p; MolPort-001-783-218; Jsp000912; CCRIS 3796; Undecane [UN2330] [Flammable liquid]; EC 214-300-6; UND; undecyl group; 4-01-00-00487 (Beilstein Handbook Reference); KSC176C3J; Undecane; ANW-42095; 175476-97-8; DSSTox_RID_76285; AC1L23G2; n-Undecane, 99% 50g; Undekan; Undecane, 99%; QSPL 058; 17398EC4-D16F-42F6-8A27-60F8EC075469; BRN 1697099; Undecane, >=99%; TR-002350; InChI=1/C11H24/c1-3-5-7-9-11-10-8-6-4-2/h3-11H2,1-2H; UNDECAN-2-YL; MCULE-7319807036; NSC 66159; EINECS 214-300-6; J-002689; RSJKGSCJYJTIGS-UHFFFAOYSA-N; NCGC00254001-01; DTXSID9021689; n-C11H24; U0002; S0283; undecan; DSSTox_GSID_21689; SC-79237; CHEMBL132474; Undecane, analytical standard; JV0QT00NUE; MFCD00008959; Hendekan; HSDB 5791; CH3-[CH2]9-CH3; NCGC00247896-01; C-28174; CC-33184; N-UNDECANE; AKOS005145675; FT-0633353; AN-20593; 61193-21-3; 55101-35-4; KS-00000WJI; NSC66159; NSC-66159; I14-60624; ZINC1693211; Hendecane; Decane, methyl-; n-Hendecane; LMFA11000591; CHEBI:46342; TRA0090240; Undecane [UN2330] [Flammable liquid]; DB-041031; CTK0H6134; RTR-002350; Tox21_300076;LMFA11000001; Tridekan; InChI=1/C13H28/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3-13H2,1-2H; CH3-[CH2]11-CH3; 629-50-5; 91490_FLUKA; 442713_SUPELCO; HSDB 5727; n-Tridecane; EINECS 211-093-4; NSC66205; T57401_ALDRICH; Tridecane; CHEBI:35998; NSC 66205; TRIDECANE, N-; C13834;Tridekan; UNII-114P5I43UJ component IIYFAKIEWZDVMP-UHFFFAOYSA-N; MCULE-7749861366; U393; DB-054344; Tridecane_GurudeebanSatyavani; ACMC-209t6w; C13H28; C13834; N-TRIDECANE; 757DB156-6441-49B0-A824-1532074AC0F6; NCGC00257175-01; IIYFAKIEWZDVMP-UHFFFAOYSA-N; Tridecane, >=99%; TL8004327; MolPort-003-933-018; LS-157141; AN-22061; STL301147; CAS-629-50-5; tridecan; LMFA11000001; SC-74775; AC1L1ZHL; LTBB002872; DSSTox_CID_7266; C-28190; InChI=1/C13H28/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3-13H2,1-2H; Tridecane, 99.0%; TRA0008560; I14-59696; KSC353S8D; UNII-FW7807707B component IIYFAKIEWZDVMP-UHFFFAOYSA-N; S0285; Dodecane, methyl-; AKOS016011009; FT-0632663; Tridecane, analytical standard; Alkanes, C12-14; MFCD00008979; UNII-A3LZF0L939; DSSTox_GSID_27266; RT-000404; CHEMBL135694; tridecyl group; KS-00000XDT; ST24031950; HSDB 5727; EINECS 211-093-4; AC1Q28TY; DSSTox_RID_78377; FT-0082500; DTXSID6027266; CC-33178; A3LZF0L939; Tox21_303043; NSC-66205; Tridecane; CH3-[CH2]11-CH3; CTK2F3981; TRD; EC 211-093-4; NSC66205; AK115985; ANW-42102; 629-50-5; CHEBI:35998; NSC 66205; TRIDECANE, N-; ZINC1693738;n-tridecane;TRD | C30H46O9 | [C@]1([H])(OC([H])([H])[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]2([H])C([H])([H])[C@]3([H])[C@@](C([H])([H])O[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([H])( C4=C([H])C(=O)OC4([H])[H])C([H])([H])C5([H])[H])[C@]56O[H])[C@@]6([H])C([H])([H])C3([H])[H])C([H])([H])C2([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN057969 | Azelex | 2,4 azelaic acid; NCGC00093565-03; Azelaic acid [USAN:INN]; Azelaic acid; NCGC00093565-04; KBio1_000532; 458317_ALDRICH; Acide azelaique [French]; Azelaic acid, technical grade; NSC 19493; SH-441; AI3-06299; Azelaic acid (USAN); Finacea; Emerox 1110; 1,9-Nonanedioic acid; 27825-99-6; NCGC00093565-02; KBio2_005573; Spectrum4_000401; A96150_ALDRICH; BRN 1101094; AZ1; Heptanedicarboxylic acid; DivK1c_000532; EU-0100051; ZK 62498; Lopac-246379; NCGC00093565-06; D03034; SPBio_001089; Acido azelaico [Spanish]; NINDS_000532; 123-99-9; Nonanedioic acid; 32733-99-6; LMFA01170054; AIDS002603; Polyazelaic anhydride; SMR000059164; BSPBio_001756; NCGC00014993-01; Acidum azelaicum [Latin]; Poly(azelaic anhydride); 4-02-00-02055 (Beilstein Handbook Reference); AIDS-002603; Lepargylic acid; AGN-191861; KBioGR_000662; C08261; LS-22779; SDCCGMLS-0066619.P001; KBio2_000437; KBioSS_000437; Skinoren; Spectrum2_000995; Azelaic polyanhydride; 246379_ALDRICH; 26776-28-3; 1,7-Heptanedicarboxylic acid; MLS000069659; Spectrum3_000278; Anchoic acid; NSC19493; Emerox 1144; Spectrum5_001304; Azelaic acid polyanhydride; EINECS 204-669-1; SPECTRUM1500648; KBio3_001256; KBio2_003005; Spectrum_000057; Lopac0_000051; Finacea (TN); IDI1_000532; ZK-62498; Nonanedioic acid, homopolymer; Finevin; Skinorem; Azelex (TN) | C9H16O4 | 188.22 g/mol | C(CCCC(=O)O)CCCC(=O)O |
| TCMBANKIN058931 | acetovanillone | FT-0618638; 1-(4-Hydroxy-3-methoxyphenyl)ethanone; Ethanone, 1-(4-hydroxy-3-methoxyphenyl)-; Acetovanillone, >=98%, FG; s2425; 3'-Methoxy-4'-hydroxyacetophenone; AS03910; NSC 209524; STL141075; CCRIS 7285; AC1L1D6F; CHEMBL346919; UNII-B6J7B9UDTR; 4-Acetylguaiacol; bmse010031; NSC-2146; apocynin (acetovanillone); AC1Q46A5; SMR000752909; RL03825; ST50213415; acetovanillone ; NSC2146; MolPort-000-000-274; L911; 3-Methoxy-4-hydroxyacetophenone; 4-hydroxy -3-methoxyacetophenone; AI3-15892; 4-Acetyl-2-methoxyphenol; MLS001304972; 4hydroxy-3-methoxyacetophenone; 4-Hydroxy-3-methoxyphenyl methyl keton; DTXSID7060097; ST24030066; 4'-Hydroxy-3'-methoxyacetophenone; TIMTEC-BB SBB008060; ZINC00162515; 2-methoxy-4-acetylphenol; CM10957; InChI=1/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H; Acetophenone, 4'-hydroxy-3'-methoxy-; PubChem3315; WLN: 1VR DQ CO1; 1-(4-hydroxy-3-methoxy-phenyl)-ethanone; Acetovanillon; DB12618; I75; Acetoguaiacon; AC-11656; CS-5647; MFCD00008747; Acetoguaiacone; Acetovanyllon; KS-00000WMF; M-6166; 21432-EP2314295A1; Acetovanillone; Apocynin; BRN 0637373; TR-033392; CHEBI:2781; Acetovanillone; 1-(4-hydroxy-3-methoxyphenyl)-ethanone; HY-N0088; Apocynine; F2191-0004; EINECS 207-854-5; ZINC162515; AURORA KA-3667; LS-13569; SCHEMBL109514; MCULE-4549346345; NSC-209524; AB1003774; KSC236I5L; 4'-Hydroxy-3'-methoxyacetophenone, 98% 50g; 21432-EP2311824A1; AC1Q7AD6; 1-(4-Hydroxy-3-methoxyphenyl)-1-ethanone; 4-Hydroxy-3-methoxyphenyl methyl ketone; DFYRUELUNQRZTB-UHFFFAOYSA-N; FS-3673; Acetovanillone, analytical standard; apocynin; RTR-033392; SC-04834; Acetovanilone; ACETOPHENONE,4-HYDROXY,3-METHOXY ACETOVANILLON; bmse000584; 1-acetyl-4-hydroxy-3-methoxybenzene; BG00601273; NCGC00247065-01; 3-Metoksy-4-hydroksyacetofenon; CJ-02042; AN-4876; 4-HYDROXY-3-METHOXYACETOPHENONE; HMS3651H03; 498-02-2; 4-hydroxy3-methoxyacetophenone; 4-08-00-01814 (Beilstein Handbook Reference); CTK1D6455; I01-7005; 3-Metoksy-4-hydroksyacetofenon [Polish]; ANW-30844; NSC209524; 1-(4-hydroxy-3-methoxy-phenyl)ethanone; BBL009710; AJ-15916; AKOS BBS-00003229; STR03975; 1-(4-hydroxy-3-methoxyphenyl)ethan-1-one; BB_NC-2250; 4CN-0663; AM20090774; Q-200477; Phenol, 4-acetyl-2-methoxy; ACMC-1AHLR; B6J7B9UDTR; C11380; AKOS000120562; AK-42915; SBB008060; KB-47086; AA-504/20839006; 4'-Hydroxy-3'-methoxyacetophenone, 98% | C9H10O3 | 166.17 g/mol | CC(=O)C1=CC(=C(C=C1)O)OC |
| TCMBANKIN059441 | beta-asarone | C12H16O3 | 208.25 g/mol | CC=CC1=CC(=C(C=C1OC)OC)OC | |
| TCMBANKIN059826 | stemonamine | C18H23NO4 | 317.4 g/mol | CC1=C2CCCCN3C2(CCC3)C4(C1=O)C(=C(C(=O)O4)C)OC | |
| TCMBANKIN059964 | α-cadinol | C15H26O | 222.37g/mol | CC1=CC2C(CCC(C2CC1)(C)O)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060748 | oxotuberostemonine | C22H31NO5 | 389.54 | CCC1C(C2C(C(=O)OC23CC(N4C3=C1CCCC4)C5CC(C(=O)O5)C)C)O | |
| TCMBANKIN060751 | bisdehydroneotuberostemonine | C22H29NO4 | 371.5 g/mol | CCC1C2CCCCN3C2=C(C=C3C4CC(C(=O)O4)C)C5C1OC(=O)C5C | |
| TCMBANKIN060752 | stenine | C17H27NO2 | 277.4 g/mol | CCC1C2CCCCN3C2C(CC3)C4C1OC(=O)C4C | |
| TCMBANKIN061016 | tridecane | C13H28 | 184.36 g/mol | CCCCCCCCCCCCC | |
| TCMBANKIN061024 | tetradecane | C14H28 | 196.39 g/mol | CCCCCCCCCCCCC=C | |
| TCMBANKIN061058 | n-hexadecane | C16H34 | 226.44 g/mol | CCCCCCCCCCCCCCCC | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061085 | n-heptadecane;heptadecane;Heptadekan | C17H36 | 240.5 g/mol | CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061090 | n-octadecane;Oktadekan;octadecane | C18H38 | 254.49g/mol | CCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061111 | heneicosane | C21H44 | 296.57 | CCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061116 | n-docosane;TWT;docosane | C22H46 | 310.6 g/mol | CCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061122 | tricosane | C23H48 | 324.63 g/mol | CCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061127 | n-tetracosane | C24H50 | 338.65 | CCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061131 | PENTACOSANE | C25H52 | 352.7 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061881 | Tylophorinidine | tylophoridine | C22H23NO4 | 365.42 | COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3O)C5=CC(=C(C=C52)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab